Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Nucleic Acids Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/NAR/GNH129PMID 15452203PMCID PMC521678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs

  2005cited by this paper
• Control of siRNA expression using the Cre-loxP recombination system.

  2004cited by this paper
• Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs

  2004cited by this paper
• RNAi Therapeutics: How Likely, How Soon?

  2004cited by this paper
• Fusion of Lamellar Body with Plasma Membrane Is Driven by the Dual Action of Annexin II Tetramer and Arachidonic Acid*

  2003cited by this paper
• Protein nitration in rat lungs during hyperoxia exposure: a possible role of myeloperoxidase.

  2003cited by this paper
• Imaging the spatial distribution of transgene expression in the lungs with positron emission tomography

  2003cited by this paper
• Gene silencing in mammalian cells by PCR‐based short hairpin RNA

  2003cited by this paper
• Enhancing adenovirus‐mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisone

  2003cited by this paper
• Regulation of cell proliferation by insulin-like growth factor 1 in hyperoxia-exposed neonatal rat lung.

  2002cited by this paper
• Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro.

  2002influential reference
• siRNA-mediated gene silencing in vitro and in vivo

  2002influential reference
• A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

  2002cited by this paper
• A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

  2002cited by this paper
• A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo

  2002cited by this paper
• RNA interference

  2002cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Simplified rat intubation using a new oropharyngeal intubation wedge.

  2000cited by this paper
• The nuclear envelope, muscular dystrophy and gene expression.

  2000cited by this paper
• Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung*

  2000cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• Involvement of annexin II in exocytosis of lamellar bodies from alveolar epithelial type II cells.

  1996cited by this paper
• Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses

  1993cited by this paper

• High matrix stiffness promotes senescence of type II alveolar epithelial cells by lysosomal degradation of lamin A/C in pulmonary fibrosis

  2025cites this paper
• Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

  2020cites this paper
• Instructions for use Title The E 3 ubiquitin ligase TRIM 23 regulates adipocyte differentiation via stabilization of the adipogenic activatorPPARγ

  2019cites this paper
• The application of gene silencing in proteomics: from laboratory to clinic

  2018cites this paper
• Defining a standard and weighted mathematical index for maturation of dendritic cells

  2018cites this paper
• Instructions for use Title The E 3 ubiquitin ligase TRIM 23 regulates adipocyte differentiation via stabilization of the adipogenicactivator PPARγ

  2017cites this paper
• THE GENERATION OF SIRNAAMIRNA EXPRESSIONVECTORS

  2017influential citation
• (Pro)renin receptor contributes to regulation of renal epithelial sodium channel

  2016cites this paper
• A novel conditional gene silencing method using a tumor-specific and heat-inducible siRNA system

  2016cites this paper
• A new design of a lentiviral shRNA vector with inducible co-expression of ARGONAUTE 2 for enhancing gene silencing efficiency

  2015cites this paper
• Erratum to: A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting

  2015cites this paper
• The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ

  2015cites this paper
• A novel placental like alkaline phosphate promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting

  2015cites this paper
• Phosphodiesterase 5a Inhibition with Adenoviral Short Hairpin RNA Benefits Infarcted Heart Partially through Activation of Akt Signaling Pathway and Reduction of Inflammatory Cytokines

  2015cites this paper
• Role of Promoters and Micro RNA Backbone for Efficient Gene Silencing

  2013cites this paper
• Antisense Gene Silencing: Therapy for Neurodegenerative Disorders?

  2013cites this paper
• Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction.

  2012cites this paper
• Silencing of Notch3 Using shRNA driven by survivin promoter inhibits growth and promotes apoptosis of human T-cell acute lymphoblastic leukemia cells.

  2012cites this paper
• Cell‐selective gene silencing in prostate cancer LNCap cells using prostate‐specific membrane antigen promoter and enhancer in vitro and in vivo

  2012cites this paper
• Characterization of the cell of origin for small cell lung cancer

  2011cites this paper
• Cell type specific, traceable gene silencing for functional gene analysis during vertebrate neural development

  2011cites this paper
• Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors

  2010cites this paper
• Identification and Characterization of Bovine Pol III Promoters to Express a Short-Hairpin RNA

  2010cites this paper
• Hypoxia-response plasmid vector producing bcl-2 shRNA enhances the apoptotic cell death of mouse rectum carcinoma.

  2010cites this paper
• RNA Interference: The Next Gene‐Targeted Medicine

  2010cites this paper
• Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.

  2009cites this paper
• MicroRNA-127 modulates fetal lung development.

  2009cites this paper
• Construction of siRNA/miRNA expression vectors based on a one-step PCR process

  2009cites this paper
• The therapeutic potential of RNA interference in controlling HIV-1 replication.

  2009cites this paper
• Pharmacological targets for gene therapy in lung inflammation

  2009cites this paper
• An advanced blue-white screening method for construction of shRNA expression vectors.

  2009cites this paper
• Microrna-127 Modulates Fetal Lung Development

  2008cites this paper
• A directional recombination cloning system for restriction- and ligation-free construction of GFP, DsRed, and lacZ transgenic Drosophila reporters.

  2008cites this paper
• Conditional gene silencing in mammalian cells mediated by a stress-inducible promoter.

  2008cites this paper
• Suppression of Bcl-xL expression by a novel tumor-specific RNA interference system inhibits proliferation and enhances radiosensitivity in prostatic carcinoma cells

  2008cites this paper
• Hit selection with false discovery rate control in genome-scale RNAi screens

  2008cites this paper
• Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs.

  2008cites this paper
• [SiRNA technology, the gene therapy of the future?].

  2008cites this paper
• The design of vectors for RNAi delivery system.

  2008cites this paper
• Genome-wide screens for effective siRNAs through assessing the size of siRNA effects

  2008cites this paper
• Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic.

  2008cites this paper
• RNA interference: new therapeutics in allergic diseases.

  2008cites this paper
• Short Hairpin RNA Interference Therapy for Ischemic Heart Disease

  2008cites this paper
• Annexin A2 Interactions with Rab14 in Alveolar Type II Cells*

  2008cites this paper
• Functional involvement of Annexin-2 in cAMP induced AQP2 trafficking

  2008cites this paper
• Progress in RNA interference therapeutics

  2007cites this paper
• Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons.

  2007cites this paper
• Genomics and proteomics approaches in understanding tumor angiogenesis

  2007cites this paper
• Lipid rafts and lung surfactant secretion

  2007cites this paper
• RNA interference in mice.

  2007cites this paper
• Primer extension-based method for the generation of a siRNA/miRNA expression vector.

  2007cites this paper
• shRNA driven by Pol II/T7 dual-promoter system effectively induce cell-specific RNA interference in mammalian cells.

  2007cites this paper
• A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells

  2007cites this paper
• A novel approach for the construction of multiple shRNA expression vectors

  2007cites this paper
• RNA interference for α-ENaC inhibits rat lung fluid absorption in vivo

  2006cites this paper
• Viral-based modelling and correction of neurodegenerative diseases by RNA interference

  2006cites this paper
• Promises and Challenges in Developing RNAi as a Research Tool and Therapy for Neurodegenerative Diseases

  2006cites this paper
• Employment of microRNA profiles and RNA interference and antagomirs for the characterization and treatment of respiratory disease

  2006cites this paper
• A Novel Function of Ionotropic γ-Aminobutyric Acid Receptors Involving Alveolar Fluid Homeostasis*

  2006cites this paper
• Mammalian Pol III Promoter H1 can Transcribe shRNA Inducing RNAi in Chicken Cells

  2006cites this paper
• Delivery of RNA Interference

  2006cites this paper
• Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells

  2006cites this paper
• RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo.

  2006cites this paper
• Transsynaptic tracing by in situ complementation of a deletion mutant neurotropic virus

  2006cites this paper
• RNA interference: From gene silencing to gene-specific therapeutics

  2005cites this paper
• An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi

  2005cites this paper
• RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancer.

  2004cites this paper
• Peripheral Nervous System

  1988cites this paper